FIRM FIXED PRICENO SET ASIDE USED.

GENSCRIPT USA INC - CUSTOM ANTISERUM

PIID: 75N93021P00884

Signed Date: Jan 7, 2026Effective Date: Jun 30, 2021End Date: Closed on Jul 2, 2021

Key Details

Dollars Obligated

$12,910.28

Base & All Options

$-30.45

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

325413 - IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Product Service Code

6505 - DRUGS AND BIOLOGICALS

Extent Competed

NOT COMPETED UNDER SAP

Number of Offers

Place of Performance

PISCATAWAY, NJ, 088543918, CD-NJ-06

Description

CUSTOM ANTISERUM

Contractor Information

Contractor: GENSCRIPT USA INC

UEI: KVLBRRAQ6UX1

CAGE Code: 5THB5

Location: PISCATAWAY, NJ

Similar Awards

ADVANCED DEVELOPMENT OF A NAAT MULTIPLEX RESPIRATORY PATHOGEN TEST FOR PROFESSIONAL POINT-OF- CARE (CLIA WAIVED) AND AT-HOME OTC USE WITH THE CUE HEALTH MONITORING SYSTEM (READER) AND CUE SAMPLE WAND

SIRO DIAGNOSTICS, INC.

$28.3M

ZSU CEPHEID GENEXPERT REQUIRES GROUP B REAGENTS KITS

CEPHEID

$3.7M

MSU CEPHEID TESTING KITS

CEPHEID

$1.2M

TPSU CEPHEID TESTING KITS

CEPHEID

$756,310

DELIVERY ORDER FOR REAGENTS AND CONSUMABLES FOR GOVENRMENT-OWNED ROCHE BENCHMARK ULTRA IMMUNOSTAINERS IN SUPPORT OF NIH/NCI/CCR/CLINICAL IMMUNOHISTOCHEMISTRY LABORATORY OF THE LABORATORY OF PATHOLOGY (LP)

ROCHE DIAGNOSTICS CORPORATION

$600,000

View Full Record on USASpending.gov